Search over 3,000 reports

    Endometriosis- Epidemiology Forecast to 2023

    Endometriosis- Epidemiology Forecast to 2023
    Date: Dec, 2017
    Type: Pharmaceutical Industry Report
    Pages: 40
    Geography: Global
    Delivery Timeline: 48 hrs
    SKU: DIEI0005
    DelveInsight "Endometriosis - Epidemiology Forecast To 2023" provides an overview of the epidemiology trends of Endometriosis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Endometriosis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Endometriosis. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

    Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

    Scope of the Report
    • The Report includes the prevalent population and how will it change over the next eight years.
    • Prevalent or incident cases segmented by age and sex.
    • Coverage of key Endometriosis subpopulations and its prevalent or incident cases
    • The key differences in epidemiology patterns across the seven market segments

    Key Coverage and Benefits
    • The report will help in developing business strategies by understanding the trends shaping and driving the global Endometriosis market.
    • Identifying prevalent patient populations as well as risk factors in the global Endometriosis market will help to improve product design, pricing, and launch plans.
    • Organize sales and marketing efforts by identifying the best opportunities for Endometriosis therapeutics in each of the markets covered.
    1. Report Introduction
    2. Snapshot of Total Prevalent or Incident cases by 7 MM
    3. Executive Summary
    • Key Findings
    4. Endometriosis Overview
    • Endometriosis Definition
    • Pathophysiology
    • Symptoms
    5. Etiology
    6. Risk Factors Associated with Endometriosis
    7. Disease Burden & Unmet Need in the Market
    8. Epidemiology and Patient Populations
    • Key Findings
    9. Key Sources used and Forecast Methodology
    10. Prevalent Cases and Incident Cases-2013-2023
    11. Prevalent & Incident Cases by Category-2013-2023
    • Age-Specific Prevalent/ Incident Cases of Endometriosis
    • Sex-Specific Prevalent/Incident Cases of Endometriosis
    • Disease Type Specific Prevalent/Incident Cases of Endometriosis
    12. Prevalent & Incident Cases by 7 MM-2013-2023
    • Endometriosis Epidemiology of United States-2023
    • Endometriosis Epidemiology of United Kingdom-2023
    • Endometriosis Epidemiology of Germany-2023
    • Endometriosis Epidemiology of France-2023
    • Endometriosis Epidemiology of Spain-2023
    • Endometriosis Epidemiology of Italy-2023
    • Endometriosis Epidemiology of Japan-2023
    13. Key Takeaways
    14. Appendix
    15. Report Methodology
    16. Consulting Services
    17. Disclaimer
    18. About Us
    Table 1: Clinical subtypes of Indication
    Table 2: Risk Factors
    Table 3: Prevalence cases (%) Region wise
    Table 4: Sources used for forecasting the data
    Table 5: Endometriosis Global Epidemiology, (2013-2023)
    Table 6: Prevalent Cases of Endometriosis (Ages =XX Years), US (2013-2023)
    Table 7: Prevalent Cases of Endometriosis By Sex (Males & Females), US (2013-2023)
    Table 8: Prevalent Cases By Endometriosis Sub-population, US (2013-2023)
    Table 9: Prevalent Cases of Endometriosis (Ages =XX Years), United Kingdom (2013-2023)
    Table 10: Prevalent Cases of Endometriosis By Sex (Males & Females), United Kingdom (2013-2023)
    Table 11: Prevalent Cases By Endometriosis Sub-population, United Kingdom (2013-2023)
    Table 12: Prevalent Cases of Endometriosis (Ages =XX Years), Germany (2013-2023)
    Table 13: Prevalent Cases of Endometriosis By Sex (Males & Females), Germany (2013-2023)
    Table 14: Prevalent Cases By Endometriosis Sub-population, Germany (2013-2023)
    Table 15: Prevalent Cases of Endometriosis (Ages =XX Years), France (2013-2023)
    Table 16: Prevalent Cases of Endometriosis By Sex (Males & Females), France (2013-2023)
    Table 17: Prevalent Cases By Endometriosis Sub-population, France (2013-2023)
    Table 18: Prevalent Cases of Endometriosis (Ages =XX Years), Italy (2013-2023)
    Table 19: Prevalent Cases of Endometriosis By Sex (Males & Females), Italy (2013-2023)
    Table 20: Prevalent Cases By Endometriosis Sub-population, Italy (2013-2023)
    Table 21: Prevalent Cases of Endometriosis (Ages =XX Years), Spain (2013-2023)
    Table 22: Prevalent Cases of Endometriosis By Sex (Males & Females), Spain (2013-2023)
    Table 23: Prevalent Cases By Endometriosis Sub-population, Spain (2013-2023)
    Table 24: Prevalent Cases of Endometriosis (Ages =XX Years), Japan (2013-2023)
    Table 25: Prevalent Cases of Endometriosis By Sex (Males & Females), Japan (2013-2023)
    Table 26: Prevalent Cases By Endometriosis Sub-population, Japan (2013-2023)
    Figure 1: Prevalence cases (%) Region wise
    Figure 2: Sources used for forecasting the data
    Figure 3: Endometriosis Global Epidemiology, (2013-2023)
    Figure 4: Prevalent Cases of Endometriosis (Ages =XX Years), US (2013-2023)
    Figure 5: Prevalent Cases of Endometriosis By Sex (Males & Females), US (2013-2023)
    Figure 6: Prevalent Cases By Endometriosis Sub-population,US (2013-2023)
    Figure 7: Prevalent Cases of Endometriosis (Ages =XX Years), United Kingdom (2013-2023)
    Figure 8: Prevalent Cases of Endometriosis By Sex (Males & Females), United Kingdom (2013-2023)
    Figure 9: Prevalent Cases By Endometriosis Sub-population,United Kingdom (2013-2023)
    Figure 10: Prevalent Cases of Endometriosis (Ages =XX Years), Germany (2013-2023)
    Figure 11: Prevalent Cases of Endometriosis By Sex (Males & Females), Germany (2013-2023)
    Figure 12: Prevalent Cases By Endometriosis Sub-population,Germany (2013-2023)
    Figure 13: Prevalent Cases of Endometriosis (Ages =XX Years), France (2013-2023)
    Figure 14: Prevalent Cases of Endometriosis By Sex (Males & Females), France (2013-2023)
    Figure 15: Prevalent Cases By Endometriosis Sub-population,France (2013-2023)
    Figure 16: Prevalent Cases of Endometriosis (Ages =XX Years), Italy (2013-2023)
    Figure 17: Prevalent Cases of Endometriosis By Sex (Males & Females), Italy (2013-2023)
    Figure 18: Prevalent Cases By Endometriosis Sub-population,Italy (2013-2023)
    Figure 19: Prevalent Cases of Endometriosis (Ages =XX Years), Spain (2013-2023)
    Figure 20: Prevalent Cases of Endometriosis By Sex (Males & Females), Spain (2013-2023)
    Figure 21: Prevalent Cases By Endometriosis Sub-population,Spain (2013-2023)
    Figure 22: Prevalent Cases of Endometriosis (Ages =XX Years), Japan (2013-2023)
    Figure 23: Prevalent Cases of Endometriosis By Sex (Males & Females), Japan (2013-2023)
    Figure 24: Prevalent Cases By Endometriosis Sub-population,Japan (2013-2023)
    Endometriosis Disease Overview

    Endometriosis Prevalence

    Endometriosis Incidence

    Endometriosis Risk Factors

    Endometriosis Epidemiology

    Endometriosis Patient Populations

    Endometriosis Diagnosed Patients

    Endometriosis Forecast

    Endometriosis Epidemiology Forecast

    Endometriosis Treated patients/population

    • Single User License
      (20% Off)
      $2,750.00
    • Site License
      (30% Off)
      $5,500.00
    • Global License
      (40% Off)
      $8,250.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap